Table 3.2.

States and Respective Guidelines and/or Protocols Referenced

State	Guideline(s) and/or Protocol(s)
Arizona 5-6	** N/A
Arkansas62	“Nicotine Replacement Therapy Statewide Protocol – Arkansas State Board of Pharmacy”
California10	“16 CCR § 1746.2. Protocol for Pharmacists Furnishing Nicotine Replacement Products” which incorporates reference to the *Treating Tobacco Use and Dependence Guideline
Colorado17	“Colorado State Board of Pharmacy Approved Statewide Protocol for Dispensing Tobacco Cessation Products” which incorporates reference to the *Treating Tobacco Use and Dependence Guideline
Idaho 28-29	*Treating Tobacco Use and Dependence Guideline only
Indiana9	“Indiana State Department of Health Protocol for Dispensing Tobacco Cessation Products under Statewide Standing Order” which incorporates reference to the *Treating Tobacco Use and Dependence Guideline
Iowa63	“Nicotine Replacement Tobacco Cessation Statewide Protocol – Iowa Board of Pharmacy” which incorporates reference to the *Treating Tobacco Use and Dependence Guideline
Kentucky82	“Tobacco Cessation Therapy Protocol v2 – Approved 12/11/2019” which incorporates reference to the *Treating Tobacco Use and Dependence Guideline
Maine 41	*Treating Tobacco Use and Dependence Guideline only
Minnesota76	“Pharmacist Prescribing Protocol Nicotine Replacement Medication – Minnesota Board of Pharmacy” which incorporates reference to the *Treating Tobacco Use and Dependence Guideline
Missouri56	“The Board has not approved or adopted a standard screening procedure. Instead, pharmacists should use their professional judgment to select screening procedures/criteria appropriate for your practice setting. The following resources may be helpful and include clinical screening guidelines from other state/federal entities: ● Clinical Practice Guideline – Treating Tobacco Use and Dependence (U.S. Dept. of Health and Human Services, Public Health Services) ● Indian Health Services Pharmacist Tobacco Cessation Clinic Protocol ● APhA Guidance for Expanding Pharmacy-Based Tobacco Cessation Services Within the Appointment-Based Model”
New Hampshire 58-59	** N/A
New Mexico 60-61	“Protocol for Pharmacist Prescribing for Tobacco Cessation – New Mexico Pharmacist prescribing of tobacco cessation, as intended to support and pursuant to, New Mexico Board of Pharmacy Regulation (16.19.26)” which incorporates reference to the *Treating Tobacco Use and Dependence Guideline
North Carolina 64-66	“Clinical Pharmacist Practitioner Protocol granted by individual physician-pharmacist relationships”
North Dakota68	“Chapter 61-04-15. Limited Prescriptive Authority for Tobacco Cessation Therapies”
Ohio 69-71	** N/A
Oregon77	“Preventive Care – Tobacco Cessation-NRT (Nicotine Replacement Therapy) and Non-NRT Statewide Drug Therapy Management Protocol for the Oregon Pharmacist”
Utah86	“Utah Guidance for Tobacco Cessation Products” which incorporates reference to the *Treating Tobacco Use and Dependence Guideline
Vermont 87-88	** N/A
Virginia 89-90	** N/A
West Virginia 92-93	** N/A

^*Treating Tobacco Use and Dependence Guideline = US Department of Health and Human Services, Public Health Services, Clinical Practice Guideline: Treating Tobacco Use and Dependence: 2008 Update